Literature DB >> 2110916

Postheparin plasma diamine oxidase in health and intestinal disease.

T Rokkas1, S Vaja, G M Murphy, R H Dowling.   

Abstract

In animals, the distribution of the enzyme diamine oxidase is confined, almost exclusively, to the small bowel mucosa. In humans, plasma diamine oxidase is at or below assay detection limits but can be liberated into the circulation from binding sites in the intestine by i.v. heparin. Therefore, the authors wished to see if diamine oxidase could be released by a low and safe dose of heparin (5000 U) and if the resultant area under the concentration-time curve would provide a noninvasive marker of segmental intestinal disease. In 17 control subjects, the mean area under the curve (following administration of 5000 U i.v. heparin) was 35.9 +/- 5.0 (SEM) mU.L-1.2 h-1; in 6 individuals studied on two separate occasions, postheparin plasma diamine oxidase profiles were reproducible (r = 0.98; p less than 0.001). The longitudinal distribution of diamine oxidase in the gastrointestinal tract, measured in 12 gastric, 16 jejunal, 6 ileal, and 18 colonic biopsies, was similar in humans to that found in animals. In patients with normal peroral biopsies, there was a linear relationship between jejunal mucosal and postheparin plasma diamine oxidase activities (r = 0.84; p less than 0.01). The areas under the curve in controls were then compared with those in patients with segmental intestinal diseases: 21 with ileal disease with or without colonic Crohn's disease (10 unoperated and 11 with ileal resection), 7 with non-Crohn's ileal resection, 8 with ulcerative colitis, 10 with untreated and 7 with treated celiac disease (6 studied before and after a gluten-free diet), and 5 studied during total parenteral nutrition and again after resumption of oral feeding. The results in the 18 ileectomized patients were subdivided into those with major (arbitrarily greater than 75 cm) and minor (less than 75 cm) resections. Areas under the curve were markedly reduced in nonresected Crohn's patients (6.0 +/- 1.79 mU.L-1.2 h-1; p less than 0.001 vs. controls), correlating inversely, in a first-order relationship, with disease activity (r = 0.82; p less than 0.001) and returning toward normal in 4 patients achieving disease remission. Low areas under the curve in total parenteral nutrition patients (4.5 +/- 0.9; p less than 0.001) were also reversible on resumption of oral feeding. However, areas under the curve were not significantly lower in patients with limited ileal resection (less than or equal to 75 cm), with celiac disease (untreated and treated), or ulcerative colitis than in controls.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110916     DOI: 10.1016/0016-5085(90)91081-g

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Enteral nutrition and the small intestine.

Authors:  A P Jenkins; R P Thompson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

2.  Congestion of superior mesenteric veins and small bowel mucosal injury after endoscopic treatment of esophageal varices in patients with portal hypertension.

Authors:  H Toyoda; M Nakao; Y Ogura; K Takagi; K Osakabe; Y Horiguchi; H Imai; H Sakamoto; H Uno; M Kamiya; H Nakano
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Lymphatic diamine oxidase secretion stimulated by fat absorption is linked with histamine release.

Authors:  Yong Ji; Yasuhisa Sakata; Xiaoming Li; Chao Zhang; Qing Yang; Min Xu; Armin Wollin; Wolfgang Langhans; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-02-14       Impact factor: 4.052

4.  Evaluation of diamine oxidase activity (DAO) in the rat intestinal mucosa by measuring expired 14CO2 after oral administration of 14C-putrescine.

Authors:  T Bamba; A Sasaki; S Hosoda
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

5.  Factors affecting plasma postheparin diamine oxidase activity.

Authors:  J S Thompson; D A Burnett; W P Vaughan
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

6.  Postheparin plasma diamine oxidase values in the follow up of patients with small bowel Crohn's disease.

Authors:  L D'Agostino; S Pignata; B Daniele; M Visconti; C Ferraro; G D'Adamo; G Tritto; G Ambrogio; G Mazzacca
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

7.  Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients.

Authors:  Thomas Boehm; Birgit Reiter; Robin Ristl; Karin Petroczi; Wolfgang Sperr; Thomas Stimpfl; Peter Valent; Bernd Jilma
Journal:  Allergy       Date:  2019-01-01       Impact factor: 13.146

8.  Early-Life Intervention Using Fecal Microbiota Combined with Probiotics Promotes Gut Microbiota Maturation, Regulates Immune System Development, and Alleviates Weaning Stress in Piglets.

Authors:  Quanhang Xiang; Xiaoyu Wu; Ye Pan; Liu Wang; Chenbin Cui; Yuwei Guo; Lingling Zhu; Jian Peng; Hongkui Wei
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.